Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

KB Filion, LM Lix, HY Oriana, S Dell'Aniello, A Douros… - bmj, 2020 - bmj.com
Objective To compare the risk of cardiovascular events between sodium glucose
cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors among …
被引用次数：99 相关文章
[HTML] nih.gov

[HTML][HTML] Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

KB Filion, LM Lix, HY Oriana, S Dell'Aniello, A Douros… - The BMJ, 2020 - ncbi.nlm.nih.gov
Objective To compare the risk of cardiovascular events between sodium glucose
cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors among …

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

KB Filion, LM Lix, OHY Yu, S Dell'Aniello, A Douros… - BMJ, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Objective</jats: title>< jats: p> To
compare the risk of cardiovascular events between sodium glucose cotransporter 2 (SGLT2) …

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

KB Filion, LM Lix, OH Yu… - BMJ (Clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective To compare the risk of cardiovascular events between sodium glucose
cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors among …

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events

KB Filion, LM Lix, OHY Yu, S Dell'Aniello… - BMJ: British Medical …, 2020 - JSTOR
OBJECTIVE To compare the risk of cardiovascular events between sodium glucose
cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors among …

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.

KB Filion, LM Lix, OH Yu, S Dell'Aniello… - … (Clinical Research ed …, 2020 - europepmc.org
Objective To compare the risk of cardiovascular events between sodium glucose
cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors among …
[PDF] cnodes.ca

[PDF][PDF] Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

KB Filion, LM Lix, OHY Yu, S Dell'Aniello, A Douros… - bmj, 2020 - cnodes.ca
Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events:
multi-database retrospective cohort s Page 1 the bmj | BMJ 2020;370:m3342 | doi: 10.1136/bmj.m3342 …

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

KB Filion, LM Lix, HY Oriana… - BMJ: British Medical …, 2020 - search.proquest.com
Objective To compare the risk of cardiovascular events between sodium glucose
cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors among …
[HTML] bmj.com

[HTML][HTML] Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

KB Filion, LM Lix, HY Oriana, S Dell'Aniello, A Douros… - BMJ, 2020 - bmj.com
Objective To compare the risk of cardiovascular events between sodium glucose
cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors among …

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.

KB Filion, LM Lix, OH Yu, S Dell'Aniello… - … (Clinical Research ed …, 2020 - europepmc.org
Objective To compare the risk of cardiovascular events between sodium glucose
cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors among …